La fibra de carbono, un material compuesto de carbono extremadamente resistente y ligero, ha revolucionado diversas industrias en las últimas décadas. Inicialmente desarrollada para aplicaciones aeroespaciales, esta innovadora sustancia ha encontrado su camino en una amplia gama de apl …
Las múltiples aplicaciones de la fibra de carbono Read More »
Consolidation between primary care physicians and large health systems led to increased costs per patient, according to a new study published in JAMA.
The payer, which brings in the bulk of its revenue from Medicare, is fighting back against a rule finalized earlier this year to claw back overpayments in the increasingly popular MA program.
The new version of the test can report more cancer-related gene mutations, and 23andMe can add variants in the future under an agreement with the FDA.
23andMe wins FDA clearance to test for expanded set of BRCA cancer risk variants Read More »
The plaintiff said disclosures to Google are “particularly problematic” because his use of Gmail meant his personal information was “automatically linked to his real identity.”
The appointment comes less than three months after former CEO Francis deSouza stepped down following a proxy battle.
Illumina names Agilent’s Jacob Thaysen as its next CEO Read More »
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) and Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the completion of Mirum’s previously announced acquisition of Travere’s bile acid product portfolio that includes Cholbam® (cholic acid) and Chenodal® (chenodiol), two medications addressing rare diseases in high-need settings (the “Asset Purchase”).
Tris Pharma, Inc. (Tris), today announced new data from a human abuse potential (HAP) study of cebranopadol (TRN-228) which suggest the investigational compound has significantly lower abuse potential compared to both schedule II and schedule IV opioids.
Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19.
Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world, today announced the commercial launch of ASPYRE®-Lung in the US.
Biofidelity announces the commercial launch of ASPYRE-Lung in the US Read More »
